Myasthenia gravis, atypical polyneuropathy and multiple autoimmune phenomena in the same patient, with HLA-immunogenetic profile expectable for Greek chronic inflammatory demyelinating polyneuropathy: a case report

References

• Souto EB, Lima B, Campos JR, et al. Myasthenia gravis: state of the art and new therapeutic strategies. J Neuroimmunol. 2019;337:577080.
   PubMed Web of Science ®Google Scholar
• Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2(10):797–804.
   PubMed Web of Science ®Google Scholar
• Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med. 2001;7(3):365–368.
   PubMed Web of Science ®Google Scholar
• Deitiker PR, Oshima M, Smith RG, et al. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006;39(4):277–288.
   PubMed Web of Science ®Google Scholar
• Çebi M, Durmuş H, Yılmaz V, et al. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG). Clin Exp Immunol. 2019;197(2):214–221.
   PubMed Web of Science ®Google Scholar
• Niks EH, Kuks JB, Roep BO, et al. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology. 2006;66(11):1772–1774.
   PubMed Web of Science ®Google Scholar
• Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R, et al. [Autoimmune diseases and multiple sclerosis]. Rev Neurol. 2005;40(10):594–597.
   PubMed Web of Science ®Google Scholar
• Zonana MF, Reyes E, Weisman AK. Coexistence of four autoimmune diseases in one patient: the kaleidoscope of autoimmunity. J Clin Rheumatol. 2002;8(6):322–325.
   PubMed Web of Science ®Google Scholar
• Nagarajan M, Maasila AT, Dhanapriya J, et al. Systemic lupus erythematosus and myasthenia gravis: a rare association. Indian J Nephrol. 2019;29(1):62–64.
   PubMed Web of Science ®Google Scholar
• Bekircan-Kurt CE, Tuncer Kurne A, Erdem-Ozdamar S, et al. The course of myasthenia gravis with systemic lupus erythematosus. Eur Neurol. 2014;72(5–6):326–329.
   PubMed Web of Science ®Google Scholar
• Garcia-Alfonso C, Bernal-Macias S, Garcia-Pardo Y, et al. Coexistence of systemic lupus erythematosus and myasthenia gravis: an unusual case of polyautoimmunity. Reumatologia Clinica. 2018.
   PubMed Web of Science ®Google Scholar
• Scaioli V, Andreetta F, Mantegazza R. Unusual neurophysiological and immunological findings in myasthenia gravis: a case report. J Peripher Nerv Syst. 2004;9(2):92–97.
   PubMed Web of Science ®Google Scholar
• Mori M, Kuwabara S, Nemoto Y, et al. Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection. J Neurol Sci. 2006;240(1–2):103–106.
   PubMed Web of Science ®Google Scholar
• Falcone M, Scalise A, Minisci C, et al. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Neurol Sci. 2006;27(1):58–62.
   PubMed Web of Science ®Google Scholar
• Vina ER, Fang AJ, Wallace DJ, et al. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheumatism. 2005;35(3):175–184.
   PubMed Web of Science ®Google Scholar
• Kumazawa K, Sobue G, Okamoto H, et al. [Two cases of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with Graves' disease]. Rinsho Shinkeigaku. 1991;31(7):768–771.
   PubMedGoogle Scholar
• Feeney DJ, Pollard JD, McLeod JG, et al. HLA antigens in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 1990;53(2):170–172.
   PubMed Web of Science ®Google Scholar
• Anagnostouli MC, Acquaviva T, Artemiadis AK, et al. HLA-DRB1* alleles genotyping in chronic inflammatory demyelinating polyneuropathy in Greek patients. J Peripher Nerv Syst. 2014;19(2):187–189.
   PubMed Web of Science ®Google Scholar
• Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2002;25(1):26–30.
   PubMed Web of Science ®Google Scholar
• Hughes RA, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13(4):326–332.
   PubMed Web of Science ®Google Scholar
• Saperstein DS, Katz JS, Amato AA, et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001;24(3):311–324.
   PubMed Web of Science ®Google Scholar
• Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990;40(7):1067–1072.
   PubMed Web of Science ®Google Scholar
• Marsh SG. Nomenclature for factors of the HLA system, update June 2012. Tissue Antigens. 2012;80(3):289–293.
   PubMedGoogle Scholar
• Cros P, Allibert P, Mandrand B, et al. Oligonucleotide genotyping of HLA polymorphism on microtitre plates. Lancet (London, England). 1992;340(8824):870–873.
   PubMed Web of Science ®Google Scholar
• Roitberg-Tambur A, Friedmann A, Safirman C, Markitziu A, Ben-Chetrit E, Rubinow A, Moutsopoulos HM, Stavropoulos E, Skopouli FN, Margalit H, et al. Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Human immunology 1993;36(4):235–242. doi:https://doi.org/10.1016/0198-8859(93)90130-s
   PubMed Web of Science ®Google Scholar
• Vlachoyiannopoulos PG, Dafni UG, Pakas I, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Moutsopoulos HM. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. Annals of the Rheumatic Diseases 2000;59(5):359–367. doi:https://doi.org/10.1136/ard.59.5.359
   PubMed Web of Science ®Google Scholar
• Chan KH, Lachance DH, Harper CM, et al. Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve. 2007;36(5):651–658.
   PubMed Web of Science ®Google Scholar
• Kieseier BC, Dalakas MC, Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology. 2002;59(12 Suppl 6):S7–S12.
   PubMed Web of Science ®Google Scholar
• Rentzos M, Anyfanti C, Kaponi A, et al. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population. J Clin Neurosci. 2007;14(3):229–235.
   PubMed Web of Science ®Google Scholar
• Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther. 2004;102(3):177–193.
   PubMed Web of Science ®Google Scholar
• Weinreb H, Klein J, Kupersmith M. Ocular myasthenia gravis and chronic inflammatory polyradiculoneuropathy. N Y State J Med. 1986;86(8):439–442.
   PubMedGoogle Scholar
• Bolz S, Totzeck A, Amann K, et al. CIDP, myasthenia gravis, and membranous glomerulonephritis - three autoimmune disorders in one patient: a case report. BMC Neurol. 2018;18(1):113.
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhang J, Zhang B, et al. The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis. Neurosciences (Riyadh). 2018;23(1):66–70.
   PubMed Web of Science ®Google Scholar
• Han YS, Kim BH, Kim TH, et al. Autoimmune hepatitis in a patient with myasthenia gravis and thymoma–a report on the first case in Korea. Korean J Internal Med. 2000;15(2):151–155.
   PubMedGoogle Scholar
• Kikuchi H, Hayashi N, Nakajima T, et al. A case report of autoimmune hepatitis with myasthenia gravis. Nihon Shokakibyo Gakkai Zasshi. 1988;85(10):2261–2264.
   PubMedGoogle Scholar
• Romi F, Hong Y, Gilhus NE. Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Curr Opin Immunol. 2017;49:9–13.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Sanghi A, Agarwal M, et al. “Three in One" - polyautoimmunity with multiple autoimmune syndrome. J Assoc Physicians India. 2018;66(1):95–97.
   PubMedGoogle Scholar
• Costenbader KH, Gay S, Alarcon-Riquelme ME, et al. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev. 2012;11(8):604–609.
   PubMed Web of Science ®Google Scholar
• Rojas-Villarraga A, Toro CE, Espinosa G, et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev. 2010;9(4):229–232.
   PubMed Web of Science ®Google Scholar
• Lu MC, Li KJ, Hsieh SC, et al. Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus. J Microbiol Immunol Infect. 2006;39(6):471–475.
   PubMedGoogle Scholar
• Balbi VA, Montenegro B, Pitta AC, et al. Autoimmune hepatitis in 847 childhood-onset systemic lupus erythematosus population: a multicentric cohort study. Adv Rheumatol. 2018;58(1):43.
   PubMedGoogle Scholar
• Vaiopoulos G, Sfikakis PP, Kapsimali V, et al. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J. 1994;70(828):741–745.
   PubMed Web of Science ®Google Scholar
• Haq RU, Fries TJ, Pendlebury WW, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol. 2000;57(12):1745–1750.
   PubMedGoogle Scholar
• Anyfantakis D, Symvoulakis EK, Barbounakis E, et al. A fatal case of seronegative, late-onset systemic lupus erythematosus presenting with motor sensory axonal polyneuropathy. Mod Rheumatol. 2014;24(5):858–861.
   PubMed Web of Science ®Google Scholar
• Simmons SC, Smith ML, Chang-Miller A, et al. Antinuclear antibody-negative lupus nephritis with full house nephropathy: a case report and review of the literature. Am J Nephrol. 2015;42(6):451–459.
   PubMed Web of Science ®Google Scholar
• Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2019;71(9):1400–1412.
   PubMed Web of Science ®Google Scholar